[55] Alizée Pace, Alex J. Chan, and Mihaela van der Schaar. Poetree: Interpretable policy learning with adaptive decision trees. In International Conference on Learning Representations, 2021.
[56] Keisuke Hirano, Guido W Imbens, and Geert Ridder. Efficient estimation of average treatment effects using the estimated propensity score. *Econometrica*, 71(4):1161-1189, 2003.
[57] Donald B Rubin. Estimating causal effects from large data sets using propensity scores. Annals of internal medicine, 127(8_Part_2):757-763, 1997.
[58] Guido W Imbens and Donald B Rubin. Causal inference in statistics, social, and biomedical sciences. Cambridge University Press, 2015.
[59] Guido W Imbens and Donald B Rubin. Rubin causal model. In Microeconometrics, pages 229-241. Springer, 2010.
[60] Steven Piantadosi. Clinical trials: a methodologic perspective. John Wiley & Sons, 2017.
[61] Stuart J Pocock. Clinical trials: a practical approach. John Wiley & Sons, 2013.
[62] Lawrence M Friedman, Curt D Furberg, David L DeMets, David M Reboussin, and Christopher B Granger. Fundamentals of clinical trials. Springer, 2015.
[63] Rebecca DerSimonian and Nan Laird. Meta-analysis in clinical trials. Controlled clinical trials, 7(3):177-188, 1986.
[64] Ahmed Alaa, Alex J. Chan, and Mihaela van der Schaar. Generative time-series modeling with fourier flows. In International Conference on Learning Representations, 2020.
[65] Joel Z. Leibo, Edgar Due nez Guzmán, Alexander Sasha Vezhnevets, John P. Agapiou, Peter Sunehag, Raphael Koster, Jayd Matyas, Charles Beattie, Igor Mordatch, and Thore Graepel. Scalable evaluation of multi-agent reinforcement learning with melting pot. In International Conference on Machine Learning, pages 6187-6199. PMLR, 2021.
[66] Oriol Vinyals, Timo Ewalds, Sergey Bartunov, Petko Georgiev, Alexander Sasha Vezhnevets, Michelle Yeo, Alireza Makhzani, Heinrich Kuttler, John Agapiou, Julian Schrittwieser, et al. Starcraft ii: A new challenge for reinforcement learning. arXiv preprint arXiv:1708.04782, 2017.
[67] Tom Stepleton. The pycolab game engine, 2017.
[68] Alex J. Chan and Mihaela van der Schaar. Scalable bayesian inverse reinforcement learning. In International Conference on Learning Representations, 2020.
[69] Paul W Holland. Statistics and causal inference. Journal of the American statistical Association, 81(396):945-960, 1986.
[70] Vikram Kilambi, Kevin Bui, and Sanjay Mehrotra. Livsim: an open-source simulation software platform for community research and development for liver allocation policies. Transplantation, 102(2), 2018.
[71] Mohd Shoaib, Utkarsh Prabhakar, Sumit Mahlawat, and Varun Ramamohan. A discrete-event simulation model of the kidney transplantation system in rajasthan, india. Health Systems, 11 (1):30-47, 2022.
[72] Shoaib Mohd, Navonil Mustafee, Karan Madan, and Varun Ramamohan. Leveraging healthcare facility network simulations for capacity planning and facility location in a pandemic. Available at SSRN 3794811, 2021.
[73] Cecilia Nardini. The ethics of clinical trials. *Ecancermedicalscience*, 8, 2014.
[74] Jack Cuzick, Robert Edwards, and Nereo Segnan. Adjusting for non-compliance and contamination in randomized clinical trials. Statistics in medicine, 16(9):1017-1029, 1997.
[75] David Maxwell Chickering and Judea Pearl. A clinician's tool for analyzing non-compliance. In Proceedings of the National Conference on Artificial Intelligence, pages 1269-1276, 1996.
[76] Osvald Nitski, Amirhossein Azhie, Fakhar Ali Qazi-Arisar, Xueqi Wang, Shihao Ma, Leslie Lilly, Kymberly D Watt, Josh Levitsky, Sumeet K Asrani, Douglas S Lee, et al. Long-term mortality risk stratification of liver transplant recipients: real-time application of deep learning algorithms on longitudinal data. The Lancet Digital Health, 3(5):e295–e305, 2021.
[77] Ina Jochmans, Marieke van Rosmalen, Jacques Pirenne, and Undine Samuel. Adult liver allocation in eurotransplant. Transplantation, 101(7):1542-1550, 2017.